MCID: GST026
MIFTS: 19

Gastric Fundus Cancer

Categories: Cancer diseases, Gastrointestinal diseases

Aliases & Classifications for Gastric Fundus Cancer

MalaCards integrated aliases for Gastric Fundus Cancer:

Name: Gastric Fundus Cancer 12
Gastric Fundus Carcinoma 12 69
Malignant Neoplasm of Fundus of Stomach 12
Malignant Tumor of Fundus of Stomach 12
Malignant Neoplasm of Gastric Fundus 69
Carcinoma of Fundus of Stomach 12
Cancer of Fundus of Stomach 12
Ca Fundus - Stomach 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10538 DOID:6700
ICD10 33 C16.1
ICD9CM 35 151.3
NCIt 47 C8398

Summaries for Gastric Fundus Cancer

MalaCards based summary : Gastric Fundus Cancer, is also known as gastric fundus carcinoma, and has symptoms including abdominal pain and dyspepsia. The drugs Triamcinolone and Immunosuppressive Agents have been mentioned in the context of this disorder. Affiliated tissues include brain.

Related Diseases for Gastric Fundus Cancer

Comorbidity relations with Gastric Fundus Cancer via Phenotypic Disease Network (PDN):


Active Peptic Ulcer Disease Deficiency Anemia
Stomach Cancer

Symptoms & Phenotypes for Gastric Fundus Cancer

UMLS symptoms related to Gastric Fundus Cancer:


abdominal pain, dyspepsia

Drugs & Therapeutics for Gastric Fundus Cancer

Drugs for Gastric Fundus Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 46)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
2 Immunosuppressive Agents Phase 4,Phase 2
3 Anti-Inflammatory Agents Phase 4,Phase 2
4 glucocorticoids Phase 4,Phase 2
5 Hormone Antagonists Phase 4,Phase 2
6 Hormones Phase 4,Phase 2
7 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2
8 triamcinolone acetonide Phase 4
9 Triamcinolone diacetate Phase 4
10 Triamcinolone hexacetonide Phase 4
11
Ranibizumab Approved Phase 3,Phase 1,Phase 2 347396-82-1 459903
12 Angiogenesis Inhibitors Phase 3,Phase 1,Phase 2
13 Angiogenesis Modulating Agents Phase 3,Phase 1,Phase 2
14
Bevacizumab Approved, Investigational Phase 2,Phase 1 216974-75-3
15
Carboplatin Approved Phase 2 41575-94-4 10339178 498142 38904
16
Etoposide Approved Phase 2 33419-42-0 36462
17
Melphalan Approved Phase 2 148-82-3 4053 460612
18
Vincristine Approved, Investigational Phase 2 2068-78-2, 57-22-7 5978
19
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743
20 Pharmaceutical Solutions Phase 1, Phase 2
21 Alkylating Agents Phase 2
22 Antimitotic Agents Phase 2
23 Antineoplastic Agents, Phytogenic Phase 2
24 Etoposide phosphate Phase 2
25 Topoisomerase Inhibitors Phase 2
26 Anesthetics Phase 2
27 Antiemetics Phase 2
28 Antineoplastic Agents, Hormonal Phase 2
29 Autonomic Agents Phase 2
30 BB 1101 Phase 2
31 Dexamethasone acetate Phase 2 1177-87-3
32 Gastrointestinal Agents Phase 2
33 HIV Protease Inhibitors Phase 2
34 Peripheral Nervous System Agents Phase 2
35
protease inhibitors Phase 2
36 histidine Nutraceutical Phase 1, Phase 2
37 Antibodies Phase 1
38 Antibodies, Monoclonal Phase 1
39 Immunoglobulins Phase 1
40
Nitroglycerin Approved, Investigational 55-63-0 4510
41
Carbon monoxide Approved 630-08-0 281
42
Menthol Approved 2216-51-5 16666
43
Methylene blue Investigational 61-73-4
44 Vasodilator Agents
45 Photosensitizing Agents
46
Proton pump inhibitors

Interventional clinical trials:

(show all 21)

id Name Status NCT ID Phase Drugs
1 TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy Active, not recruiting NCT02379000 Phase 4 Triamcinolone Acetonide
2 Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases Completed NCT02219529 Phase 3
3 A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. Completed NCT02034006 Phase 3 Ranibizumab
4 A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab Recruiting NCT02859441 Phase 1, Phase 2 Ranibizumab;E10030
5 Conservative Treatments of Retinoblastoma Recruiting NCT02866136 Phase 2 VP16, carboplatin;Melphalan;VP16, carboplatin, vincristin;Carboplatin + laser day 1 (chemothermotherapy);intravitreal Melphalan (local treatment)
6 Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma Terminated NCT00432445 Phase 2
7 Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma Terminated NCT01471054 Phase 2 Ozurdex;Bevacizumab
8 Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma Completed NCT00750399 Phase 1 Ranibizumab;ranibizumab
9 Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome Completed NCT00089765 Phase 1 Ranibizumab
10 EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome Completed NCT00056199 Phase 1 EYE001
11 Banded Sleeve Gastrectomy Versus Banded Ring Gastric Bypass in Morbidly Obese Patients Unknown status NCT00873405
12 Obestatin Change in Distal Gastrectomy Completed NCT00822718
13 Intravenous NTG to Preserve Gastric Microcirculation During Gastric Tube Reconstruction Completed NCT00335010 Nitroglycerin
14 Nodal Status in Adenocarcinoma of the Esophagus an Cardia Completed NCT01635595
15 PDT and Periodontal Treatment in DMT2 Patients Completed NCT01964833
16 Trial on Delay Phenomenon Utility in Preventing Anastomotic Leakage After an Esophagectomy Recruiting NCT02432794
17 Prognostic Value of Hemodynamic Disturbances in Rhegmatogenous Retinal Detachment (CRADO-RED) Recruiting NCT02618083
18 Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer Recruiting NCT03030404
19 Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation Recruiting NCT01820117
20 Fundic Gland Polyps and Proton Pump Inhibitor (PPI) Drugs Terminated NCT01130363
21 Photoacoustic Endoscopy in Endometrial Cancer Withdrawn NCT01498237 Early Phase 1

Search NIH Clinical Center for Gastric Fundus Cancer

Genetic Tests for Gastric Fundus Cancer

Anatomical Context for Gastric Fundus Cancer

MalaCards organs/tissues related to Gastric Fundus Cancer:

39
Brain

Publications for Gastric Fundus Cancer

Variations for Gastric Fundus Cancer

Expression for Gastric Fundus Cancer

Search GEO for disease gene expression data for Gastric Fundus Cancer.

Pathways for Gastric Fundus Cancer

GO Terms for Gastric Fundus Cancer

Sources for Gastric Fundus Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....